ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for monitor Customisable watchlists with full streaming quotes from leading exchanges, such as LSE, NASDAQ, NYSE, AMEX, Bovespa, BIT and more.

CCCC C4 Therapeutics Inc

3.8488
-0.1512 (-3.78%)
Last Updated: 16:28:55
Delayed by 15 minutes

Income Statement

Balance Sheet

Cash Flow

Quarter End Sep 2022Dec 2022Mar 2023Jun 2023Dec 2023Mar 2024Jun 2024Sep 2024
USD (US$)USD (US$)USD (US$)USD (US$)USD (US$)USD (US$)
Total Revenue 6.75M2.85M3.76M6.42M3.26M3.04M12.01M15.36M
Operating Income -32.49M-38.29M-36.23M-73.8M-37.43M-32.22M-21.44M-28.24M
Pre Tax Income -31.96M-37.19M-34.78M-70.7M-34.48M-28.36M-17.72M-24.67M
Net Income -31.96M-37.19M-34.78M-70.7M-34.75M-28.36M-17.72M-24.67M
Preferred Dividends 00000000
Basic Earnings Per Share (EPS) 00000000
EBIT -32.49M-38.29M-36.23M-73.8M-37.43M-32.22M-21.44M-28.24M
EBITDA -32.07M-37.77M-35.68M-72.79M-37M-31.77M-20.99M-27.8M
Year End 31 December 2023 201820192020202120222023
USD (US$)USD (US$)USD (US$)USD (US$)USD (US$)USD (US$)
Total Revenue 19.36M21.38M33.2M45.79M31.1M20.76M
Operating Income -16.39M-35.45M-60.45M-82.13M-129.53M-139.03M
Pre Tax Income -15.71M-33.3M-66.96M-83.89M-128.18M-131.21M
Net Income -24.11M-42.57M-66.34M-83.89M-128.18M-132.49M
Preferred Dividends -8.4M-8.47M0000
Basic Earnings Per Share (EPS) -18.004-29.83-1.538-1.723-2.618-2.689
EBIT -16.4M-35.13M-60.45M-82.13M-129.53M-139.03M
EBITDA -15.12M-33.86M-58.83M-80.64M-127.86M-137.15M